Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.3 - $7.51 $24,380 - $34,546
4,600 New
4,600 $26,000
Q3 2023

Nov 14, 2023

SELL
$4.52 - $8.9 $1.34 Million - $2.64 Million
-296,400 Reduced 51.15%
283,100 $1.28 Million
Q2 2023

Aug 14, 2023

BUY
$4.79 - $8.3 $2.78 Million - $4.81 Million
579,500 New
579,500 $3.43 Million
Q1 2023

May 15, 2023

SELL
$5.3 - $10.93 $4.26 Million - $8.78 Million
-803,000 Closed
0 $0
Q4 2022

Feb 14, 2023

BUY
$4.1 - $8.94 $3.29 Million - $7.18 Million
803,000 New
803,000 $4.28 Million
Q2 2022

Aug 15, 2022

SELL
$6.92 - $15.97 $1.55 Million - $3.57 Million
-223,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$11.52 - $22.05 $2.57 Million - $4.92 Million
223,300 New
223,300 $3.22 Million

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.